Resource & Clinical Hub
Clinical Science & Research Center
Evidence summaries for medical directors, compliance officers and activity leaders. What each approach has been shown to do, in whom, and how strongly, and what it has not been shown to do. Every figure is cited, and every summary lists its limits.
Evidence library
Reading settings
Settings are kept in this browser, for every Research Center page.
-
Research summaryEmerging evidence
Pattern Drawing and the Brain: What EEG Studies of Zentangle Show
EEG studies found changes in alpha and other brain rhythms while adults drew Zentangle patterns, and small trials in older adults report less anxiety and depression. None has yet studied people living with dementia.
8 min read · 15 sources · Neuroscience, Art and coloring
-
Research summaryModerate evidence
Reminiscence Work in Dementia Care: What the Evidence Shows
A Cochrane review of 22 trials found a very small benefit of reminiscence for cognition and, for individual work, a slight benefit for mood, with no harms. Individual reminiscence and care-home programs did best.
3 min read · 1 source · Reminiscence
-
Research summaryStrong evidence
Cognitive Stimulation Therapy: The Best-Supported Group Activity in Dementia Care
Group cognitive stimulation probably brings a small benefit to thinking and memory, roughly equal to a six-month delay in expected decline, and slight gains in quality of life. England’s NICE recommends it for mild to moderate dementia.
4 min read · 4 sources · Cognitive stimulation
-
Research summaryModerate evidence
Music-Based Activities in Dementia Care: Mood, Behavior and Connection
Five or more music sessions probably ease depressive symptoms slightly and may improve overall behavior, according to a 2025 Cochrane review of 30 studies. Effects on agitation and memory remain unproven.
3 min read · 1 source · Music
-
WhitepaperPublished standard
Print for Macular Degeneration and Low Vision: The Evidence Behind Cognicopia’s Print Standard
More than half of nursing home residents in one study had impaired vision, and macular degeneration takes central vision first. This whitepaper sets out the research and published standards behind Cognicopia’s type sizes, contrast and typeface.
5 min read · 9 sources · Vision and print
-
WhitepaperEmerging evidence
Seeing Clearly in Dementia: Contrast, Clutter and Visual Perception
Alzheimer’s disease can reduce contrast sensitivity and color and depth perception beyond normal aging. A small study found high-contrast tableware increased food and drink intake. Clear, high-contrast pages apply the same principle.
3 min read · 2 sources · Vision and print, Art and coloring
-
WhitepaperModerate evidence
Dignity-First Activity Design: Adult Materials and Respectful Communication
Speaking to people with dementia in “elderspeak” makes resistance to care more likely, and training staff to stop reduces it. The same respect belongs in printed materials: adult subjects, adult language, no childish design.
3 min read · 5 sources · Dignity and communication
-
Case scenarioIllustrative scenario
Case Scenario: Structuring the Late Afternoon in a Memory Care Neighborhood
An illustrative scenario, not a report of a real facility, showing how an activity director could use the evidence and Cognicopia’s tools to plan afternoons, and what to measure over 90 days.
3 min read · 4 sources · Programs and operations, Cognitive stimulation, Music
-
Case scenarioIllustrative scenario
Case Scenario: Adapting Activities for a Resident Living With Macular Degeneration
An illustrative scenario showing how a team can recognize vision loss behind withdrawal from activities, and adapt print, lighting and approach.
3 min read · 5 sources · Vision and print, Programs and operations
-
Regulatory briefFederal regulation
Regulatory Crosswalk: CMS Requirements for Activities, Dementia Care and Staff Training
A plain-language crosswalk of the CMS requirements that shape activity programs (F550, F583, F656, F675, F679, F680, F744 and F947) and where Cognicopia’s tools can support them. It supports compliance work; it does not guarantee compliance.
4 min read · 7 sources · Regulation
No document matches those choices.
For facility boards
A board packet, in one click
An evidence and value summary a director can take to the administrative board: the decision in brief, the evidence behind each approach, regulatory alignment, a value worksheet with the license price and the facility’s own figures, a 90-day plan with measures, answers to the questions boards ask, and every reference. Letter size, ready to print or attach.
What’s inside
- The decision in brief, with privacy and risk
- The evidence at a glance, rated and cited
- Regulatory alignment: F550 to F947
- The value worksheet: $349.00 a year per building, cost per resident, staff time
- Implementation and measurement over 90 days
- Questions boards ask
- The vendor’s disclosure and every reference
Personalize the packet (optional)
How we rate evidence
Each document carries one rating: the strength of the evidence it summarizes. A rating describes the research, never Cognicopia’s products, which have not been tested in clinical trials of their own.
| Rating | What it means | Documents |
|---|---|---|
| Strong evidence | Systematic reviews of randomized trials agree, or a national clinical guideline recommends it. | Cognitive stimulation |
| Moderate evidence | Randomized trials or systematic reviews point the same way, but effects are small or findings vary. | Reminiscence evidence, Music in dementia care, Dignity-first design |
| Emerging evidence | Small trials, pilot or single-group studies. Promising, not settled. | Pattern drawing and the brain, Visual perception in dementia |
| Published standard | Published accessibility and design standards and the research behind them, not trials of outcomes. | Print for low vision |
| Federal regulation | The text of federal requirements and the surveyor guidance that interprets them. | Regulatory crosswalk |
| Illustrative scenario | A composite example of applying the evidence. Not a real facility, and no outcome data. | Structuring the late afternoon, Adapting for macular degeneration |
How we write these summaries
- Sources. Peer-reviewed studies, Cochrane systematic reviews, national clinical guidelines, published accessibility standards and the text of federal regulations. Every figure links to its source.
- What was measured, in whom. Each study is described by its design, its participants, what it measured, what it found and its caveats, so a reader can judge how far it applies to their residents.
- Limits, always. Every summary ends with what the evidence does not show. Where a principle is reasoned from evidence rather than tested directly, the page says so.
- Composites are labeled. Case scenarios are composites written to show how evidence can be applied. They describe no real facility or resident, and report no outcomes.
- Review. Every summary was checked against its sources on September 30, 2026. Corrections are welcome through the contact page.
- Disclosure. Cognicopia makes the activity tools these pages mention, and wrote these summaries. The summaries report what the research found, including where it found little or nothing.
Educational summaries for professionals, not medical advice. Regulations and guidance change; check the current text before relying on a regulatory summary.